Pharmabiz

Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas

Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas: Boston Friday, February 6, 2026, 17:00 Hrs [IST] Balt Inc, a global ...
Pharmabiz

Zydus receives US FDA Orphan Drug Designation for desidustat to treat sickle cell disease

Zydus receives US FDA Orphan Drug Designation for desidustat to treat sickle cell disease: Our Bureau, Mumbai Friday, February 6, 2026, 16:30 Hrs [IST] Zydus, a leading, discovery ...
Pharmabiz

Jubilant Pharmova in Q3 clocks 17% income growth at Rs. 2,143 crore, PAT up by 17%

Jubilant Pharmova in Q3 clocks 17 per cent total income growth which is at Rs. 2,143 crore as against Rs. 1,831 crore in the corresponding quarter last year. Normalised PAT after adjusting for ...
Pharmabiz

Immunic presents additional phase 2 CALLIPER trial data for vidofludimus calcium in patients with progressive MS at the ACTRIMS Forum 2026

Immunic presents additional phase 2 CALLIPER trial data for vidofludimus calcium in patients with progressive MS at the ACTRIMS Forum 2026: New York Friday, February 6, 2026, 16:0 ...
Pharmabiz

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide: San Diego Friday, February ...
Pharmabiz

BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India & UAE

BC Platforms partners with OmicsBank to expand access to large-scale real-world and multi-omics data from India & UAE: Zurich Friday, February 6, 2026, 14:00 Hrs [IST] BC Platform ...
Pharmabiz

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Daiichi Sankyo begins patient dosing in phase 1/2 trial of DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: Tokyo Friday, February 6, 2026, 10:00 Hrs [I ...
Pharmabiz

OPKO Health, Entera Bio expand collaboration and license agreement to advance the first oral long-acting PTH analog

OPKO Health, Entera Bio expand collaboration and license agreement to advance the first oral long-acting PTH analog: Miami Friday, February 6, 2026, 12:00 Hrs [IST] OPKO Health In ...
Pharmabiz

Preventive cholera vaccination resumes as global supply reaches critical milestone

Preventive cholera vaccination resumes as global supply reaches critical milestone: Geneva Friday, February 6, 2026, 11:00 Hrs [IST] Gavi, the Vaccine Alliance, UNICEF, and the Wo ...
Pharmabiz

Dr Reddy’s, Humane World for Animals India and InStem unveils report on non-animal testing methods

Our Bureau, Bengaluru Friday, February 6, 2026, 09:00 Hrs [IST] ...
Pharmabiz

BioAsia 2026 to convene the world’s leading science, AI, and industry pioneers driving the TechBio revolution

BioAsia 2026 to convene the world’s leading science, AI, and industry pioneers driving the TechBio revolution: Our Bureau, Mumbai Thursday, February 5, 2026, 17:45 Hrs [IST] Bio ...
Pharmabiz

Cipla launches ‘Win Over Weight’ campaign, igniting a national conversation on obesity care in India

Cipla launches ‘Win Over Weight’ campaign, igniting a national conversation on obesity care in India: Our Bureau, Mumbai ...